Key terms

About RCUS

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest RCUS news

Today 1:33am ET Arcus Biosciences: A Buy Rating Based on Clinical Pipeline Strength and Financial Stability by TipRanks Yesterday 8:04am ET Analysts Are Bullish on Top Healthcare Stocks: Olema Pharmaceuticals (OLMA), Arcus Biosciences (RCUS) by TipRanks Yesterday 8:02am ET Wedbush Reaffirms Their Buy Rating on Arcus Biosciences (RCUS) by TipRanks Yesterday 6:05am ET Arcus Biosciences: Holding Steady Amidst Progress and Uncertainties by TipRanks Yesterday 3:30am ET Analysts Offer Insights on Healthcare Companies: Editas Medicine (EDIT), Arcus Biosciences (RCUS) and Maravai Lifesciences Holdings (MRVI) by TipRanks May 01 6:21am ET Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Mereo Biopharma Group Plc (MREO) and Arcus Biosciences (RCUS) by TipRanks May 01 6:20am ET Promising Outlook for Arcus Biosciences Anchored by Strong Clinical Trials and Strategic Market Positioning by TipRanks Apr 28 1:33pm ET Arcus Biosciences price target lowered to $37 from $44 at Citi by TipRanks Apr 12 6:50am ET Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Arcus Biosciences (RCUS) by TipRanks Feb 25 11:29pm ET Evaluating Arcus Biosciences’ Casdatifan Potential and Strategic Position in RCC Treatment Landscape by TipRanks Feb 22 7:11am ET Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Arcus Biosciences (RCUS) and United Therapeutics (UTHR) by TipRanks Feb 22 5:40am ET Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Ionis Pharmaceuticals (IONS) and Icon (ICLR) by TipRanks Feb 22 5:07am ET Barclays Sticks to Its Buy Rating for Arcus Biosciences (RCUS) by TipRanks Feb 21 4:11pm ET Arcus Biosciences reports Q4 EPS ($1.08), consensus ($1.02) by TipRanks

No recent press releases are available for RCUS

RCUS Financials

1-year income & revenue

Key terms

RCUS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

RCUS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse
Close-up detail of the Disney+ app icon on an Apple iPhone 12 Pro smartphone screen, on November 11, 2020. (Photo by Phil Barker/Future Publishing via Getty Images)
Phil Barker/Future Publishing/Getty Images
Disney just had its worst day in a year and a half